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The mathematical form for a dose-time-response model is ideally not just a convenience for
summarizing or fitting a particular data set-it represents a hypothesis. The more this hypothesis
reflects a mechanistically sophisticated view of the likely reality, the more it can lead to potentially
informative validating or invalidating types of predictions about the results of real experiments and
(in the long run) reasonably credible predictions outside the range of direct observations. This
paper first reviews some distinctive features of the nervous system and neurotoxic responses
and theoretically explores some basic quantitative implications of these features. Relationships
are derived for how dose-response relationships for the inhibition of function should depend on
the numbers of neurons in series or redundant parallel arrangements that are required or capable
of performing the function. Previous work is reviewed in which some less nervous-system-
specific features were the foci of quantitative risk-assessment modeling for specific neurotoxic
end points. These include a) rates of repair of putatively reversible damage in the case of
acrylamide; b) human interindividual variability in susceptibility to fetal/developmental effects in
the case of methylmercury; and c) opportunities to use intermediate biomarkers to assist in
integrated animal toxicological and epidemiologic investigations of the chronic cumulative risks
posed by agents that contribute to neuronal loss with increasing age and pathology. - Environ
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Introduction-The Why,
What, and How of
Mechanism-based Modeling
Now, my own suspicion is that the universe
is not only queerer than we suppose; but
queerer than we can suppose.
-J.B.S. Haldane (1)
Weiss (2) and others have previously
noted a number of distinctive properties
of the nervous system and neurotoxicity
that make appropriate and productive
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approaches to the problem ofquantitative
modeling of neurotoxic risks depart very
seriously from the well-explored paradigm
that has been used for quantitative risk
assessment for genetically acting carcino-
gens. In particular, parameters measuring
neurologic function are often continuous
rather than quantal (3), and there is a
diverse set of modes of response of the
nervous system to toxic insults (e.g.,
acute-reversible, acute-irreversible, chronic-
reversible, chronic-irreversible, latent-irre-
versible). Moreover, the observable modes
of response often differ even for the same
chemical as a function of dose rate and
aggregated dose.
Quantitative risk assessment inevitably
involves the projection of available infor-
mation beyond the experimental or obser-
vational circumstances where it was
collected. In general, an interpretive frame-
work is imported from our background
understanding of the system, and this
is used to both select relevant data for
analysis and interpret the significance of
the data for the different circumstances in
which we want to make risk predictions.
We can say that such a framework has a
causal mechanistic basis to the extent that
it arises from particular causal processes
with defined quantitative implications. For
example, some cases in which mechanistic
understanding gives rise to particularly
well-founded quantitative predictions
include the following:
* The high-concentration approach to
saturation ofMichaelis-Menten enzyme
kinetics arises naturally from funda-
mental considerations of the finite
binding capacity of protein molecules
for substrates, and the finite processing
times required for enzyme-catalyzed
reactions (4).
* Expectations of low-concentration
linearity in chemical transport and reac-
tion arise from fundamental considera-
tion of mass action-the fact that all
those processes ultimately result from
the frequency of molecular collisions,
which depends linearly on the concen-
tration ofeach reactant (when tempera-
ture is held constant).
* The development of physiologically
based pharmacokinetic modeling over
the last 20 years has been based on the
recognition that the dynamics oftrans-
port and accumulation ofsimple organ-
ics in different body compartments can
be at least approximately understood
based on equilibrium partition coeffi-
cients, physical compartment sizes, and
blood flow rates (5,6).
* The expectation of normal concentra-
tion distributions used in gaussian
plume modeling (of the dispersion of
air pollutants) arises ultimately from
the central limit theorem: addition or
subtraction of many random numbers
yields a normal distribution. This is
applied to air dispersion via the recog-
nition that with air turbulence, individ-
ual molecules and small parcels of air
are being subjected to many random
translations in different directions,
equivalent to addition and subtraction
of random numbers. Similarly, where
differences among individuals in inter-
nal body burdens of a toxicant arise
from the multiplication of many ran-
dom variables (e.g., concentration in an
exposure medium such as fish; amount
ofthe medium taken in; and residence
time of the toxicant in the body) log-
normal distributions are expected and
frequently found (because multiplica-
tion or division ofmany random num-
bers is equivalent to the addition or
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subtraction of their logarithms) (7).
Similar reasoning has been used to
support the traditional assumption ofa
lognormal distribution of thresholds
used in log-probit dose-response analy-
sis (8) for quantal noncancer effects.
The key point to understand is that the
mathematical form for a dose-time-
response model is ideally not just a conve-
nience for summarizing or fitting a particu-
lar data set-it represents a hypothesis
about the state ofthe world. The more this
hypothesis reflects a mechanistically sophis-
ticated view ofthe likely reality, the more
it can lead to potentially informative vali-
dating or invalidating types ofpredictions
about the results ofreal experiments and
(in the long run) reasonably credible pre-
dictions outside the range of potential
direct observation.
To be productive in laying the ground-
work for quantitative neurotoxicity risk
assessment, mechanistic theories must help
identify a) which of the many types of
potentially obtainable data about a set of
neurotoxic responses are salient for under-
standing likely dose-time-response rela-
tionships for realistic human occupational
and environmental exposures and b) what
adjustments and adaptations need to be
made in using those data to project risks
for a large, diverse exposed human popula-
tion-recognizing that the data will be col-
lected for either small groups ofrelatively
uniform animals with well-characterized
but usually simple exposures, or sometimes
larger groups ofhaphazardly selected human
subjects with incompletely characterized
and often complicated exposures.
Beyond the challenges for risk assess-
ment projections listed above, a further set
ofdifficulties arises because the functional
tests that are used for measuring neurobe-
havioral toxicity are quite a simplified rep-
resentation of the diverse tasks that are
critical for our human functioning in
society. Exactly how does impaired per-
formance in maintaining balance on a
rotating rod, recognizing a particular pat-
tern offlashing lights, or learning to solve a
maze, translate into impaired performance
in driving a car or filling out a tax form, let
alone learning to read? Clearly, in the long
run it will be necessary to have a theory
that allows us to evaluate the significance
ofneurotoxicity data not only across differ-
ences in exposure levels-durations and
species but across rubstantial differences in
task complexity.
Models are simplifications of reality.
They are intended to represent the likely
behavior of a complex system of interest
by focusing on the behavior of a few
salient features or components of the sys-
tem. Ifthe features included in the model
are the prime determinants ofthe behavior
of the system (that is, if other variables
that could also affect the system are rela-
tively constant or relatively unimportant),
then there is a hope that the model will
reasonably accurately represent the behav-
ior ofthe system over a particular domain
ofconditions.
This paper first reviews some distinctive
features ofthe nervous system and neuro-
toxic responses that appear to be good can-
didates to be the focus of quantitative
modeling for neurobehavioral responses.
Then some basic potential quantitative
implications of these features are theo-
retically explored. Finally, some previous
work is reviewed in which some less ner-
vous-system-specific features have been
explored in quantitative risk assessment
modeling for specific neurotoxic end points.
These are a) rates of repair ofputatively
reversible damage in the case ofacrylamide,
b) human interindividual variability in sus-
ceptibility to fetal/developmental effects in
the case ofmethylmercury, and c) oppor-
tunities to use intermediate biomarkers to
assist in integrated animal toxicologic/epi-
demiological investigations ofthe chronic
cumulative risks posed by agents that con-
tribute to neuronal loss with increasing age
and pathology.
Special Features ofthe
Nervous System with Promise
for Neurotoxicity Modeling
On its face, no system ofthe body is more
intricate than the nervous system. Surely it
is an understatement to report that the
mechanistic connections between the inter-
nal processes of the nervous system and
accessible neurobehavioral end points are
incompletely understood. Nevertheless, sev-
eral decades ofscientific study have yielded
a substantial body of information-about
the structure ofthe system; about the func-
tional effects ofdamage to various portions
ofthe system; and about the capabilities of
several chemical and physical agents (e.g.,
noise) to induce damage and impair the
performance ofthe system in various ways.
At least three special features ofthe ner-
vous system seem likely to be salient for the
modeling ofsome neurotoxic risks:
Irreplaeability. Some ofthe basic ele-
ments ofthe nervous system (neurons) do
not reproduce in adults and cannot be
replaced iflost due to the action ofa toxic,
physical, or infectious agent. Neuronal
numbers decrease with normal aging in
primates (by different amounts in different
areas ofthe brain), and important progres-
sive neurologic conditions are associated
with an enhanced loss ofspecific sets of
neurons (9,10). Moreover, model systems
in which the behavioral effects of neuro-
toxic agents are found to be parallel to
behavioral effects induced by specific phys-
ical lesions in specific neural areas show
promise ofproviding a quantitative calibra-
tion ofneurotoxic damage in terms ofthe
location, extent, and severity ofphysically
observable neuronal loss (11).
Redundancy. For many tasks that the
nervous system performs, excess capacity is
available, at least in normal individuals.
This means that performance on those
tasks may not be proportionately degraded
[or, depending on the measurement sys-
tem, detectably degraded at all (12)] in
parallel with the loss or impairment of
underlying functional elements. In combi-
nation with the normal age-related decline
in neurons, this also is a likely cause of
delays ofmany years in the manifestation
of neurotoxic effects following an acute
toxicant-induced injury.
Plasticity. To a considerable extent,
when damage occurs to some elements,
function can be recovered as surviving
elements take on tasks formerly performed
elsewhere (13). In normal aging brains,
neuronal loss appears to be substantially
offset in terms offunction bydendritic pro-
liferation (14). Other adaptive responses
have also been noted at the subcellular
level. Chronic exposure to anticholinest-
erase agents, leading to excessive transmis-
sion across cholinergic synapses, leads to
compensatory down regulation of the
number of receptors for acetylcholine on
the postsynaptic membrane (15,16).
Approachesfor Mechanism-
based Modeling ofToxic
Processes in Response to
Some Special Features of
the Nervous System
From the foregoing discussion it appears
likely that at least some neurotoxic effects
are caused as a result of the inactivation
(temporary or permanent) of neurons.
Such inactivations can be treated as quan-
tal events in at least some cases, most
notably for cases involving frank cell death
such as the production ofchronic neurode-
generative conditions. (In other cases, there
will surely be graded responses even on a
cellular level, as for an agent that simply
slows conduction or changes the likelihood
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of synaptic transmission via manipulation
ofthe number or affinity ofavailable recep-
tors for a neurotransmitter, or the rate of
inactivation of a neurotransmitter after
release.)
BasicImplications ofParalielversus
SeriesArrangement ofNeurons
in Performing Functions
Treating the action ofsome neurotoxicants
as operating via quantal inactivation of
individual cells allows a relatively simple
representation of the ideas of redundancy
and varying task complexity. Redundancy
is straightforward to represent as an array
ofparallel cells, or systems ofcells, each of
which (ifnot inactivated) is capable ofper-
forming the function. Similarly, we can
imagine that one practical definition of
task complexity for the nervous system is
the length of the chain of neurons, all of
which must function properly to accom-
plish the task. Pushing the electrical anal-
ogy implicit in the previous use of the
word parallel to represent redundancy, we
can say that a functional unit in the nervous
system will often consist of some number
of cells acting in series to accomplish a
particular task.
Let Pcell survival be the probability that
an individual neuron survives an exposure
to a toxicant in a particular time period.
Pcell survival is, of course, a function oftoxi-
cant concentration; later we will use log
probit and single-hit functions to represent
this. Because all the cells acting in series
must survive for a functional unit to
remain active, we can expect that
'function preserved =(1cl survival)N [1]
where Nis the number ofcells in series in
the functional unit.
Similar reasoning yields a simple for-
mula to represent redundancy. Because all
ofthe parallel units must fail in order for
function not to be preserved, where there
is only one cell in each functional unit
we have:
pfunction preserved = 1Pall nparallel cells fail
= 1-(Pone cell fails)
= 1-(l1-Pcellsurvival
[2]
where Nis the number ofcells/functional
units capable and available to perform the
task in parallel. Combining these two
expressions, we can infer the probability
of function preservation for a system
composed of n parallel functional units,
each ofwhich consists ofNcells in series:
Pfunction preserved
-Pall n parallel functional units fail
1 [1 (Pcellsurvival)] [3]
The potential usefulness of this very
simple framework is that it can lead to
empirically testable predictions about the
relationships between a) measurable dose-
response relationships for inactivation at
the cellular level (Pcell survival as a function
of the internal concentration and time of
exposure ofthe relevant neurons); b) struc-
tural features of the multicellular system
responsible for the function (n redundant
parallel units consisting of Ncells in
series); and c) measurable dose-response
relationships for inhibition ofthe function.
This framework would be particularly
powerful for generating experimental pre-
dictions ifthe structural features could be
systematically varied in related series of
experiments. For example, the function-
inhibition dose-response behavior could be
measured for a closely related series oftasks
that are progressively more complicated for
the organism in terms ofrequiring a longer
series ofsimilar cells to work for successful
performance. Redundancy could also be
varied in quantitatively measurable ways;
for example, by comparing the dose-
response relationships for the inhibition of
function in younger versus older animals or
in animals with and without some physi-
cally or chemically generated lesion that
reduced the available size ofthe pool ofrel-
evant neurons capable ofperforming the
measured function.
The following analysis focuses on the
implications of the framework for the
relationships between the structural vari-
ables and three measurable response para-
meters: a) the IF1O, the delivered dose
required to reduce function by 10% (this
will be close to the smallest reliably mea-
surable response in many cases); b) the
IF50, the delivered dose required to reduce
function by 50%; and c) the IC50, the
delivered dose required to inactivate 50%
of the relevant cells (either reversibly or
irreversibly, depending on the action ofthe
toxicant understudy).
The idea ofdelivered dose is included
in these definitions as a reminder that the
effects ofany high-dose pharmacokinetic
nonlinearities in the relationship between
external dose and dose at the active site
may need to be the subject of a separate
modeling process.
Dose-Response Relationships
fortheInactvation
ofIndividual Cells
To derive predictions for the relationships
among these response parameters as a func-
tion of the structural variables, the only
added element we need is a dose-response
relationship for cellular inactivation. A
simple function that can be used for refer-
ence comparisons is classic one-hit inhibi-
tion, derived from the Poisson probability
ofeach cell receiving various numbers of
inactivating hits.
P -P p _e-kd
cell survival - 0 hits- [4]
where dis the dose ofthe toxicant, and kis
the number of inhibitory hits per unit
dose. This function would be expected to
result from a mechanism in which the
probability of inactivating damage to a
vitally important organelle was a simple
linear function oftoxicant concentration x
time at low doses. Setting karbitrarily at 1,
the IC for this function occurs at a dose
ofln(2 (0.693) dose units.
A more plausible general dose-response
function arises from the idea that individ-
ual cells could be presumed to be lost on a
threshold basis but with a diversity ofindi-
vidual cell thresholds arising from different
internal exposures to the toxicant (e.g.,
resulting from locations relatively close or
relatively far from a cell of another type
responsible for metabolically converting
the parent toxicant molecule to a directly
active form) and different cellular capaci-
ties for rapid detoxification or repair.
Ifthe distribution ofthresholds for inhibi-
tion of neuron units is lognormal, then
we obtain the familiar log probit dose-
response relationship ofFinney (8):
Pcell survival = Pfraction ofneuronswith thresholds overd
= 1-4T[z]
= 1-D[a+ b*log(d)] [5]
where d is dose as before and tI is the
cumulative distribution function for the
normal distribution-the area under a
normal curve below z, where z is the num-
ber ofstandard deviations above or below
the lognormal distribution of individual
cellular thresholds at the delivered dose
(d). (In the original formulation of
Finney, 5 was added to z in defining pro-
bits to avoid negative numbers, but this
will be dispensed with here.) At the IC 0,
the delivered dose exceeds the threshol5ds
ofhalfofthe neuron population, z =0 and
d= 10(-lb). b in this formulation is known
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as the probit slope-a measure of the
spread of the distribution of individual
thresholds. 1/b is the standard deviation of
the distribution of the logarithms1o of the
threshold doses.
Some preliminary indication of the
range ofprobit slopes that may be observed
in practice can be gleaned from data ana-
lyzed recently by Slikker and Gaylor (17)
on the relationship between administered
MPTP (1-methyl-4-phenyl-1,2,3,6-tetra-
hydropyridine) dose and dopamine con-
centrations in relevant regions ofthe brain
in different species. Figure 1 shows the
correspondence between the data and the
fits done by Slikker and Gaylor (17) to a
mathematical model ofthe form,
Fraction ofcontrol dopamine concentration = I+ad
[6]
where dis dose and a is a fitted constant.
Mechanistically, this model is best suited to
the representation of concentration-
response relationships for enzyme inhibi-
tion, where the dose or concentration ofthe
toxicant producing 50% inhibition is 1/a.
If, however, the action of MPTP is
taken as primarily cell killing and if we
assume that the fraction of control
dopamine concentrations observed are a
rough indication ofthe fraction ofthe rele-
vant cells that have survived treatment,
then a log probit fit to the data may yield a
preliminary indication ofthe spread ofthe
lognormal distribution ofthe thresholds of
the relevant cells. A series ofsuch fits to the
same data used by Slikker and Gaylor (17)
is shown in Figure 2.
It should be immediately noted that it
is not fair to directly compare the accuracy
ofthe fits to the data in Figure 2 to those
in Figure 1. The probit model form used
for Figure 2 has two adjustable parameters
whereas the Slikker and Gaylor model
form has only one. Figure 2 does not show
a fit to the monkey data included in Figure
1 because, with only two data points, a
two-parameter model must necessarily fit
perfectly. The probit slope for such a fit to
the monkey data is about 2, similar to that
seen in Figure 2A.
The inference to be drawn from Figure
2 is that a plausible range ofprobit slopes
for individual cellular responses in the ini-
tial analysis here should include values
from about 2 to 6. For later reference, a
probit slope of 2 represents a considerable
spread ofindividual cellular thresholds for
inhibition. Ninety-five percent of the
thresholds for such a cell population would
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Figure 1. Comparisons of Slikker and Gaylor (17) one-
parameter model fits with observed reductions in dopa-
mine concentrations following MPTP administration.
(A) Striatal dopamine in male mice. Data from Ricaurte
et al. (18). (B) Neostriatal dopamine in male mice.
Data from Sonsalla et al. (19). (C) Monkey caudate
nucleus dopamine. Data from Slikker and Gaylor(17).
be expected to be spread out over a 100-
fold range ofvalues, from 10-fold less than
the median to 10-fold greater than the
median. A probit slope of6 suggests a con-
siderably narrower 95% range-approxi-
mately 4.6-fold, from a little more than
half to a little more than double the
median value.
Figure 3 is a comparison of the three
cellular dose-inhibition relationships that
will be used for exemplary analysis here.
It can be seen that in the experimentally
measurable range (from about 10 to about
90% inhibition) the probit slope 2
function is relatively close to the one-hit
function, whereas the probit slope 6
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* Probitslope 2fit
I 20 40 60 80
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Figure 2. The two-parameter probit model fits with
observed reductions in dopamine concentrations fol-
lowing MPTP administration. (A) Striatal dopamine in
male mice. Data from Ricaurte (18); (8) neostriatal
dopamine in male mice. Data from Sonsalla et al. (19).
function has a distinctly sigmoidal shape
that is characteristic of many familiar
toxicological responses.
Derivation ofExperimentallyTestable
PredictionsforDose-Response
RelationshipsforLoss ofFunction in
Relation to Structural Parameters
(NumberofCells inSeries per
Functional UnitandNumber
ofParallelFunctionalUnits)
We can now use Equation [3] to derive
some expected relationships between the
measurable parameters defined earlier.
Figure 4 and Tables 1 and 2 show the
consequences ofparallel and series multi-
plicities based on the one-hit model of
individual cellular sensitivities. It can be
seen in Figure 4 that, as the number of
redundant parallel units is increased (for a
function dependent on only one cell in
series), the dose-response curve for func-
tional loss becomes increasingly sigmoidal
in shape, and of course the IF50 (the dose
required to produce a 50% loss offunction)
is progressively increased.
Tables 1 and 2 show the effects ofvary-
ing both redundancy and the length ofthe
chain ofcells in series. Tables 3 to 6 show
the results of similar calculations for the
Environmental Health Perspectives - Vol 104, Supplement 2 - April 996 384NEUROBEHAVIORAL RISKASSESSMENT
1.0
0.8
CD
a
0
.-
LC
LL.
0.6
0.4
O O.S 1.0
Dose
Figure 3. Comparison of one-hit, probit slope 2, and probit slope 6 dos
individual cells.
1.0
-0
CD
a1)
Co
0)
Cu
C
0
C.4
C.)
U-
0.8
0.6
0.4
0.2
0
0 0.5 1.0 1.5
Dose
Figure 4. The effect of increasing the number of redundant parallel unit
tion-one-hit dose-response model for cellular inhibition.
Table 1. Implications of a one-hit dose-response model for relationsh
parameters as a function of structural variables-1F5d1C50.
NCells in s
nCells in parallel 1 2 3
1 1.00 0.50 0.33
2 1.77 0.89 0.59
3 2.28 1.14 0.76
4 2.65 1.33 0.88
5 2.95 1.48 0.98
6 3.20 1.60 1.07
probit slope 2 and probit slope 6 individual
E Onehit cellular dose-response functions.
* Probkslope 2 Tables 1, 3, and 5 show the IF50/IC50
ratio-the ratio of the dose needed to * Probitslope 6 produce 50% inhibition ofthe function to
the dose needed to inactivate 50% of the
individual cells. As might be expected,
increasing redundancy increases this ratio
which indicates that a larger dose is needed
to inhibit 50% of the function than is
needed to inactivate 50% ofthe cells. For
functions with a high degree ofredundancy
but relatively few cells in series, substantial
effects may be detectable at lower doses by
neuropathology/neurochemistry than by
changes in function. By contrast, increasing
the length ofthe chain ofcells in series in
each functional unit decreases the IF50/1C50
ratio-indicating that the function is likely
to be 50% inhibited at a smaller dose than
1.5 2.0 is required to inactivate 50% of the cells.
Therefore for relatively demanding tasks
(defined as those requiring the correct
,e-response functions for the survival of functioning of many cells in series) with
relatively little redundancy, measures of
neurobehavioral function are likely to be
substantially inhibited at doses at which
major changes are not apparent by neuro-
E 6Cells in parallel chemistry/neuropathology measurements.
* 5 Cells inparallel A less obvious result apriori is that the
sizes of the effects of redundancy and Cells In parallel chain-length on the IF50/IC50 ratio depend
O 3 Cells in parallel critically on the amount ofinterindividual
i 2Cells in parallel variability among cells. This can be seen by
comparing the amounts of increase and
decrease in the IF50/IC50 among Tables 1,
3, and 5. A relatively wide spread of
interindividual variability (probit slope 2,
Table 3) means that the IF50 can increase
by as much as 4-fold as the redundancy is
raised from 1 to 6; and can decrease by as
much as 4- to 7-fold as the number ofcells
_ ; = ; ~~~~in series in raised from I to 6. By contrast,
when the distribution ofindividual cellular
_________________---____________- sensitivities is relatively narrow (probit
2.0 2.5 3.0 slope 6, Table 5), the increase in the IF
with the same range ofredundancy is lim-
ited to 1.6-fold, and the effect ofincreasing
ts on the sensitivity of function to inhibi the number ofcells in series from 1 to 6 is
limited to 2-fold.
A markedly different result can be seen
in Tables 2, 4, and 6-increases in both
redundancy and the number of cells in
series act in the same direction on the ,eries IF /IF ratio. Increases in both structural
10 50 4 5 6 parameters tend to reduce the difference in
0.25 0.20 0.17 the doses needed to produce 10 and 50%
0.44 0.35 0.30 loss of function and thus, increase the
0.57 0.46 0.38 steepness (sigmoid character) of the
0.66 0.53 0.44 dose-response relationship for the loss of
0.74 0.59 0.49 function. This means that in cases where
the dose-response relationship for cellular
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Table 2. Implications of a one-hit dose-response model for relationships between experimentally measurable
parameters as a function ofstructuralvariables-IFWIF50.
NCells in series
nCells in parallel 1 2 3 4 5 6
1 0.152 0.152 0.152 0.152 0.152 0.152
2 0.310 0.310 0.310 0.310 0.310 0.310
3 0.395 0.395 0.395 0.395 0.395 0.395
4 0.450 0.450 0.450 0.450 0.450 0.450
5 0.487 0.487 0.487 0.487 0.487 0.487
6 0.516 0.516 0.516 0.516 0.516 0.516
Table 3. Implications of a probit slope 2 individual cellular response model for relationships between experimen-
tally measurable parameters as a function of structural variables-IF50/IC50.
NCells in series
nCells in parallel 1 2 3 4 5 6
1 1.00 0.53 0.39 0.32 0.27 0.24
2 1.87 0.89 0.61 0.48 0.41 0.36
3 2.57 1.14 0.77 0.60 0.50 0.43
4 3.15 1.34 0.89 0.68 0.56 0.48
5 3.67 1.51 0.98 0.75 0.61 0.53
6 4.13 1.66 1.07 0.80 0.66 0.56
Table 4. Implications of a probit slope 2 individual cellular response model for relationships between experimen-
tally measurable parameters as a function ofstructuralvariables-lF1`lIC50.
NCells in series
nCells in parallel 1 2 3 4 5 6
1 0.229 0.286 0.317 0.337 0.352 0.363
2 0.308 0.381 0.419 0.443 0.461 0.475
3 0.351 0.430 0.470 0.496 0.514 0.528
4 0.380 0.461 0.502 0.528 0.547 0.562
5 0.401 0.483 0.525 0.551 0.570 0.585
6 0.417 0.500 0.542 0.569 0.588 0.602
Table 5. Implications of a probit slope 6 individual cellular dose-response model for relationships between exper-
imentally measurable parameters as afunction ofstructuralvariables-lF15JC50.
NCells in series
nCells in parallel 1 2 3 4 5 6
1 1.00 0.81 0.73 0.68 0.65 0.62
2 1.23 0.96 0.85 0.79 0.74 0.71
3 1.37 1.05 0.92 0.84 0.79 0.75
4 1.47 1.10 0.96 0.88 0.82 0.78
5 1.54 1.15 0.99 0.91 0.85 0.81
6 1.60 1.18 1.02 0.93 0.87 0.83
Table 6. Implications of a probit slope 6 individual cellular dose-response model for relationships between exper-
imentally measurable parameters as a function of structuralvariables-IFlWlC50.
NCells in series
nCells in parallel 1 2 3 4 5 6
1 0.612 0.659 0.682 0.696 0.706 0.714
2 0.675 0.725 0.748 0.762 0.773 0.780
3 0.705 0.755 0.777 0.791 0.801 0.808
4 0.724 0.772 0.795 0.808 0.818 0.825
5 0.737 0.785 0.807 0.820 0.829 0.836
6 0.747 0.794 0.815 0.828 0.838 0.844
loss can be measured, the steepness of
the dose response relationship for func-
tional loss may sometimes be inter-
pretable in terms ofsome general limits on
the redundancy and series-length of the
underlying neural system.
All ofthese results are, ofcourse, initial
expectations based on a very simple repre-
sentation of the neural systems. In some
cases some ofthe redundant pathways may
be redundant for only a portion of the
entire chain length (that is, either of two
parallel series of neurons may activate a
single neuron, which then triggers the final
response). This and other possibilities seem
likely to give rise to behavior between the
simple extremes examined above.
Overall, this framework has some
promise for integrating dose-response
information at the cellular and functional
levels oforganization with basic structural
information about the neural systems sup-
porting specific functions. The predictions
ofthis system seem mostlikely to be experi-
mentally testable in cases in which distribu-
tions ofcellular thresholds for inactivation
are relatively broad and where a graded
series of tasks can be shown to involve
increasing series chain lengths or where dif-
ferent levels ofredundancy can beproduced
by physical lesioning, simultaneous admin-
istration of other agents, etc. After such
testing, the framework has some promise
for developing expectations for how func-
tional dose-response relationships should
change for tasks involving different chain
lengths associated with different tasks and
different degrees ofredundancy that maybe
available in humans with advancing age and
progressive neuropathology.
Generic Issues in Noncancer
Risk Assessment
RepairRates ofIncipientDamage
One of the advantages of mechanistic
modeling as an aid to basic scientific inves-
tigation is that when the predictions of a
mechanistic model are refuted by subse-
quent observations, the direction offailure
can provide mechanistically interpretable
indications ofpotentially productive direc-
tions for further investigation. Work done
some years ago explored the implications of
a very simple model ofthe effects ofrepair
of putatively reversible damage on dose-
time-response data for acrylamide axono-
pathy (20). The data sets analyzed were
those that provided information on some
specific manifestation oftoxicity produced
by different combinations of acrylamide
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dose rate and duration of exposure
(21,22). The initial model for analyzing
these data was built around three assump-
tions: a) a particular adverse effect occurs
whenever a specific amount ofdamage is
accumulated in the relevant portions ofthe
nervous system (i.e., there is no appreciable
delay between the production of damage
and the manifestation of the resulting
effects); b) damage is produced at a rate
that is approximately linear with the mg
per kg dose administered to the animals;
and c) repair of the accumulated damage
occurs at a rate that depends directly on
the amount ofaccumulated damage that
there is to be repaired.
The first assumption provided the pri-
mary tool for quantitatively analyzing the
data. For each data set, the repair rate was
found that made the amount ofaccumu-
lated damage approximately equal for each
of the dose and time combinations that
were observed to produce a particular
response. Figure 5 illustrates the buildup
of internal damage to levels producing
an effect under this model, with a 2.9%
per day rate ofrepair.
Recently, new data have been analyzed
by Hattis and Crofton (23) on the dose-
rate and time responses of some motor
activity end points for acrylamide neuro-
toxicity in rats both during and after the
end ofacrylamide dosing. Without knowl-
edge ofthe posttreatment recovery results,
the data for rate ofloss offunction for the
period during dosing were fit to the initial
model, and predictions were made for the
times when various amounts offunctional
recovery should appear (23). In all cases
the predicted recovery times were distincdy
less than the times observed for the actual
recovery ofvarious amounts offunction.
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Contrary to our model expectations, three
out of the four sets of recovery measure-
ments showed some appreciable lag time
before recovery of function began to be
observable (Figure 6). The effect was most
noticeable for the two highest dose rates
and the most profound levels offunctional
impairment. Substitution of a saturable
rather than a simple linear repair process
improved the fit but did not make the
theory compatible with the data.
The lack ofadequate fit for these sim-
ple hypotheses leads us to some biologically
interesting hypotheses for possible explo-
ration in furtherwork:
* There might be functional compensa-
tion or adaptation by the organism to
overcome partial damage to a compo-
nent ofthe nervous system.
* There might be a two-stage damage
process, with the second stage ofdam-
age representing less easily reversible (or
even irreversible) damage. For such a
two-stage process, the need for acry-
lamide to act on the same neuron twice
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Figure 5. Theoretical time-dose-internal damage
functions for the best fitting repair rate (2.9%/day) for
acrylamide-induced changes in vertical motor activity.
Effect appears at 15 mg/kg/day dose. Effect appears
at 10 mg/kg/day dose.'Effectappears at6.7 mg/kg/day
dose. Data from Hattis and Crofton (23).
0
Figure
functioi
(A) Resu
for 30-d
Crofton
* There might be a more complex rela-
tionship than was assumed between the
underlying pathological events and the
resulting functional changes. Recent
data suggest that recovery offunction is
not coincident with observable repair of
physical damage. At a time point where
animals display almost complete recov-
ery offunction from a 90-day exposure
to acrylamide, histological studies yield
little evidence of tissue repair in the
peripheral nervous system. It is there-
fore possible that the functional recov-
ery is attributable to an anatomical
compensatory mechanism (i.e., plastic-
ity) such as sprouting at the neuromus-
cular junction by fibers that still work,
which can result in fewer fibers inner-
vating more muscular tissue (24,25).
These possibilities may be explored
in further experimental and dynamic
modelingwork.
InterndividualVariability
inSuseptibility
ght be expected to produce a greater One strategy in using quantal data for a
)portion ofstage 2 damage for the quantitative risk assessment is to assume
,her dose rates. that an observable response is produced
when some underlying continuous parame-
ter (e.g., internal dose or damage) exceeds
some critical threshold, as was done in the
previous section for acrylamide. Changes
in the frequency ofquantal responses as a
function of dose are therefore interpreted
as changes in the fraction ofthe population
whose individual thresholds have been
exceeded. An unusual analysis ofhuman
data ofthis type was included in a report on
seafood safety by the Institute ofMedicine
6.7mg/kg/day (26). This addresses a key issue ofwhether
10mgkg/day f D (and if so by how much) interindividual
0 20 40 60 80 100 120 140 160 variability in susceptibility for fetal and
Days developmental effects differs from inter-
individual variability in susceptibility for
effects in adults.
One of the best available (although still
quitelimited) human data sets forreproduc-
tive effects has been published by Marsh et
al. (27). For 81 mother-infant pairs, these
authors provide detailed information on the
incidence ofavarietyoffetal methylmercury
effects in relation to the maximal levels of
*10mg/kg/day mercury found in the hair ofthe mothers o 15mg/kg/day I I I I during gestation. The observations come
0 20 40 60 80 100 from an Iraqi mass-poisoning incident that
Days resulted from the distribution ofmethyl-
6. Observed patterns of loss and recovery of mercury-treated green revolution seedgrain.
n during and following acrylamide dosing. Observations of the children were made
ilts for90-day dosing and recovery. (B) Results some years after birth. Maximum mercury
lay dosing and recovery. Data From Hattis and concentrations were assessed by a series of
(23). sequential measurements along the hair
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shafts during fetal development. Log probit
dose-response fits to these data by the maxi-
mum-likelihood procedure of Finney (8)
indicate very large amounts ofinterindivid-
ual variability in response-probit slopes of
about 1 (Table 7). Analogous, but unfortu-
nately not completely comparable, analyses
ofdata for a variety ofadult effects, based
on measurements of methylmercury in
blood, suggest probit slopes in the range of
2 to 8 (Table 8). A probit slope of 1 would
imply that 95% of the population had
thresholds for effect spread over four orders
ofmagnitude, from 100-fold less than the
median to 100-fold more than the median.
Such a large amount ofinterindividual vari-
ation would imply appreciable risks (of the
order of 10-5 to 10-2), even at the much
lower dosages that are present in the diets of
people who consume relatively large
amounts of fish with relatively large
methylmercury concentrations. A probit
slope of2 would suggest less but still appre-
ciable variability with the thresholds of95%
of the population spread over a 100-fold
range in dosage, from 10-fold lower to 10-
fold higher than the threshold for the
median person.
Unfortunately, in addition to statistical
uncertainties in the determination ofthese
slopes from limited data, there are impor-
tant questions ofbiological interpretation. A
conclusion that the relationships represented
in the upper part ofTable 7 represent true
interindividual variability depends on an
assumption that the biomarker ofexposure
used in this case-the maximum hair
mercury found at any time during gesta-
tion-is the most appropriate direct causal
predictor of response that can be devel-
oped. (Other possibilities might well
include the concentration of mercury in
maternal blood at a specific sensitive time
during gestation or a weighted sum ofcon-
centrationsxduration over a specific set of
sensitive periods.) Any inaccuracy in the
assessment ofthe relevant dose used for the
analyses ofTable 7 would tend to cause a
bias in the estimation of the probit slopes
toward lower values (and hence higher esti-
mates of interindividual variability and
low-dose risks).
In recent work, the relationship
between uncertainty in the dosimeter and
estimates of the probit slope has been
quantitatively estimated (4). It was found
that measurement and estimation inaccura-
cies as large as a geometric standard devia-
tion of3 would be needed to make a true
probit slope 6 relationship appear to have a
probit slope as low as 1.
A further implication of this analysis is
that ifone were able to measure or estimate
uncertainties in the individual doses
estimated in epidemiological studies, it
would be possible to at least make an
approximate reconstruction ofthe slopes of
the underlying dose-response relationships.
Quaifying andTracing Causes of
Early Damage in Chronic Cumulatve
Neurotoxic Processes
It has been stressed that neurons do not
regenerate in adult life and that some
important neurological conditions are
caused by the chronic cumulative loss of
specific types of neurons in older people.
Because in many cases the brain can lose
considerable numbers of the relevant cells
before gross clinical signs of impairment
are obvious, exposure to agents causing this
category of conditions can proceed appar-
ently innocuously for decades without
being noticed. Even after symptoms
Table 7. Maximum likelihood log probit fitsa of fetal effects data using the method of Finney (8).
Background ED50, peak ED50 Degrees
Effect % responseb Probitslope Slope SE Intercept ppb bloodc Geom. SE Chi-square freedomd pe
Late walking 0 1.21 0.30 2.19 205 1.49 6.093 3 0.11
Late talking 7.3 1.76 0.71 0.81 244 1.38 0.689 1 0.41
Mental symptoms 2.4 0.99 0.76 1.88 1429 4.75 0.351 1 0.55
Seizures 0 1.10 0.53 1.54 1399 2.95 0.356 3 0.95
Neurol score >4 0 0.85 0.27 2.42 1047 2.54 0.874 3 0.83
Average 1.18 Sum 8.363 11 0.68
'The equation fit is probit of excess risk overbackground=intercept+(slope)*1ogl(blood Hg in ppb); data from Institute of Medicine (26). bEstimated from data in the lowest
one to three dose groups. cEstimated from the peak hair mercury data using the relationship ppb blood =4*(ppm hair). dThe number of dose groups available for analysis, less
2 for the number of parameters estimated from the data (the intercept and probit slope). 'The probability that a deviation as large as that observed between the log probit
model and the data would have been expected bychance, even ifthe log probit model were a perfect description ofthe underlying dose-response function.
Table 8.. Maximum likelihood fits ofthe Iraqi adult methylmercury effects data using the method of Finney (8).
Background ED50, ED50 Degrees
Effect % response' Probit slope Slope SE Intercept ppb bloodd Geom. SE Chi-square freedomb pC
Paresthesias 7.5 2.17 0.63 -1.64 1145 1.24 1.155 2 0.76
Ataxia 2.5 3.92 0.76 -7.67 1687 1.11 4.95 3 0.18
Visual changes 0 2.19 0.43 -2.24 2006 1.16 3.695 3 0.3
Disarthria 5 4.67 1.36 -11.2 2952 1.10 5.608 3 0.13
Hearing defects 1.3 6.42 2.17 -18.05 3877 1.10 0.209 1 0.65
Deaths 0 7.58 3.19 -23.05 5007 1.18 0.83 1 0.36
Average 4.49 Sum, adult effects 16.447 13 0.22
Sum, fetal and adult effects 24.81 24 0.42
'Estimated from data in the lowest one to three dose groups. bThe number ofdose groups available foranalysis, less 2 forthe number of parameters estimatedfrom the data (the
intercept and probitslope). cThe probabilitythata deviation as large as that observed between the log probit model and the data would have been expected bychance, even ifthe
log probit model were a perfectdescription ofthe underlying dose-response function. dBased on blood measurements made approximately65days after exposure. Forcomparison
with thefetal bloodED50 values, these data should be adjusted upward byapproximately 2-fold. Data from Institute of Medicine(26).
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appear, picking out the potentially relevant
exposures from an unmeasured lifetime of
different pursuits presents a practically
insuperable challenge to clinicians and epi-
demiologists. More timely epidemiologic
research would be greatly facilitated if
either or both of the following types of
biomarkers were developed.
Measures ofthe PastAccumulation of
Relevant Damage in People VWho Have
Not Yet Developed Clinical Illness. For
example, can our new tools for imaging the
brain be applied to take a census of how
many ofthe relevant cells are left in people
of different ages with different past expo-
sures? This would be analogous to the use
of chest X-rays, forced expiratory volume,
and forced vital capacity to assess the accu-
mulation of past respiratory damage of
chronic cumulative types. A general
schema proposed earlier (28) for the use of
biomarkers in quantitative risk assessment
for noncancer effects includes the following
elements: a) elucidate the quantitative rela-
tionships between internal dose/time of
toxicant exposure and changes in the func-
tional intermediate parameter; b) assess the
preexisting background distribution ofthe
functional intermediate parameter in the
human population; c) assess the relation-
ship between the functional intermediate
parameter and diminished physiological
performance or adverse health effects;
d) assess the magnitude of parameter
changes likely to result from specific expo-
sures in humans (taking into account
human interindividual variability in metab-
olism and other determinants ofpharmaco-
kinetics) and consequent changes in the
incidence and severity ofhealth effects; and
e) do not attempt, from the biology alone,
to determine acceptable levels ofparameter
change or exposure. (Let the policy makers
decide what changes in the incidence and
severity of health effects are acceptable in
the context of the modes of exposure and
in the light ofthe feasibility ofreducing or
avoiding the exposure.)
Measures ofthe Current Rate ofLoss
ofthe Relevant Cells. When the relevant
cells die, do they release measurable
amounts ofa distinctive form ofan enzyme
or some other component that could be
used as a biomarker? Do they, perhaps in
their death throes, emit a distinctive type
ofelectrical signal that could be picked up,
identified, and measured?
Many years ago Weiss and Spyker (29)
suggested that methylmercury might accel-
erate the loss of neurons in adult life and
contribute to a chronic cumulative process
that could fall within this category. More
recently, some support for this hypothesis
has been found in a case-control epidemio-
logic study among people in Singapore,
which has found an association between
blood levels of mercury and risk of
Parkinson's disease (30). This finding,
using a biomarker ofexposure, needs to be
followed up in confirmatory studies and
(hopefully) with the aid ofnew biomarkers
ofthe types suggested above.
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